Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 1,000 shares at $578.88 ($579K) on 2026-04-17, disclosed to the SEC on 2026-04-17.
Scheduled sale ($579k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |
| UTHR | SELL | 2024-09-05 | $1.8M | — | Filing → |